Stockscreener 앱 받기
1.66
9.93%
0.15
시간 외 거래:
1.67
0.01
+0.60%
전일 마감가:
$1.51
열려 있는:
$1.6
하루 거래량:
1.15M
Relative Volume:
1.72
시가총액:
$134.95M
수익:
$447.48M
순이익/손실:
$-14.55M
주가수익비율:
-11.07
EPS:
-0.15
순현금흐름:
$7.61M
1주 성능:
+26.72%
1개월 성능:
+13.70%
6개월 성능:
-13.09%
1년 성능:
+2.47%
1일 변동 폭
$1.60
$1.71
1주일 범위
$1.28
$1.71
52주 변동 폭
$1.28
$2.95
Accuray Inc Stock (ARAY) Company Profile
명칭
Accuray Inc
전화
608-824-2800
주소
1240 DEMING WAY, MADISON, CA
ARAY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
1.66 | 134.95M | 447.48M | -14.55M | 7.61M | -0.15 |
|
ABT
Abbott Laboratories
|
131.99 | 230.70B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.87 | 154.22B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.08 | 145.74B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.81 | 107.03B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.80 | 44.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-02-13 | 개시 | ROTH MKM | Buy |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2021-12-22 | 개시 | Loop Capital | Buy |
| 2020-01-21 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-11-01 | 업그레이드 | Citigroup | Sell → Neutral |
| 2017-12-13 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-11-30 | 개시 | Lake Street | Buy |
| 2016-12-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2015-12-22 | 개시 | RBC Capital Mkts | Sector Perform |
| 2015-11-12 | 개시 | Citigroup | Sell |
| 2015-05-01 | 재확인 | Dougherty & Company | Buy |
| 2015-01-12 | 개시 | Northland Capital | Outperform |
| 2014-01-31 | 재확인 | Dougherty & Company | Buy |
| 2014-01-29 | 재확인 | Brean Capital | Buy |
| 2013-11-11 | 재확인 | Dougherty & Company | Buy |
| 2013-08-29 | 재확인 | Dougherty & Company | Buy |
| 2011-09-20 | 재확인 | Ticonderoga | Buy |
| 2010-02-08 | 업그레이드 | Jefferies & Co | Hold → Buy |
| 2009-12-09 | 업그레이드 | UBS | Sell → Neutral |
| 2009-03-09 | 다운그레이드 | Soleil | Buy → Hold |
| 2009-01-30 | 업그레이드 | Piper Jaffray | Neutral → Buy |
| 2008-12-22 | 재확인 | Jefferies & Co | Hold |
| 2008-08-20 | 재확인 | Jefferies & Co | Hold |
모두보기
Accuray Inc 주식(ARAY)의 최신 뉴스
Accuray Third Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Accuray Presents New Data Showing Benefits Of Robotic Radiotherapy Device CyberKnife At ESTRO - Nasdaq
Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025 | ARAY Stock News - GuruFocus
Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025 - PR Newswire
ARAY: Accuray's CyberKnife System Debuts in Austria | ARAY Stock News - GuruFocus
Accuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® System - PR Newswire
Equities Analysts Offer Predictions for Accuray Q4 Earnings - Defense World
Accuray Incorporated (NASDAQ:ARAY) Shares Bought by Wells Fargo & Company MN - Defense World
Roth Capital Estimates Accuray’s Q1 Earnings (NASDAQ:ARAY) - The AM Reporter
ACCURAY INC SEC 10-Q Report - TradingView
Accuray Incorporated (NASDAQ:ARAY) Q3 2025 Earnings Call Transcript - Insider Monkey
Accuray Incorporated (NASDAQ:ARAY) Delivered A Weaker ROE Than Its Industry - Yahoo Finance
ARAY’s Market Whiplash: -29.80% YTD Decline, -21.91% Plunge in 30 Days - investchronicle.com
Should investors be concerned about ARAY’s high price-to-sales ratio? - uspostnews.com
ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y - Barchart.com
Accuray Inc [ARAY] Shares Fall -4.32 % on Wednesday - knoxdaily.com
Ready to Jump After Recent Trade: Accuray Inc (ARAY) - Sete News
Accuray (ARAY) Exceeds Q3 Revenue Expectations with Strong Perfo - GuruFocus
Accuray Reports Fiscal 2025 Third Quarter Financial Results | AR - GuruFocus
JPMorgan Chase & Co. Has $481,000 Stake in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Accuray Inc (ARAY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Global Challenges - Yahoo Finance
Accuray: Fiscal Q3 Earnings Snapshot - New Haven Register
Accuray Inc (ARAY) Q3 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Accuray Inc (ARAY) Q3 Earnings: EPS of -$0.01 Beats Estimates, R - GuruFocus
Accuray earnings beat by $0.02, revenue topped estimates - Investing.com
Accuray (ARAY) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Accuray Q3 FY25 presentation: revenue jumps 12%, guidance revised downward - Investing.com
Accuray Reports Fiscal 2025 Third Quarter Financial Results - PR Newswire
Pancreatic Cancer Market Set to Witness Significant Growth - openPR.com
Medical Devices Market Is Booming So Rapidly | Fresenius, Johnson & Johnson, Accuray - openPR.com
XTX Topco Ltd Trims Stake in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Accuray Incorporated (NASDAQ:ARAY) Shares Purchased by Geode Capital Management LLC - Defense World
Stock Market Recap: Accuray Inc (ARAY) Concludes at 1.51, a 3.42 Surge/Decline - DWinneX
Healthcare Robotics Market Next Big Thing: Major Giants- Hocoma, Toyota, Accuray - newstrail.com
Accuray to Report Third Quarter Fiscal 2025 Financial Results on April 30, 2025 | ARAY Stock News - GuruFocus
Accuray to Report Third Quarter Fiscal 2025 Financial Results on April 30, 2025 - Yahoo Finance
Philippines Radiotherapy Market Deep Research Report with - openPR.com
Sei Investments Co. Has $65,000 Holdings in Accuray Incorporated (NASDAQ:ARAY) - Defense World
StockNews.com Upgrades Accuray (NASDAQ:ARAY) to Buy - Defense World
ARAY Stock Gains as China Approves Latest Radiation Therapy Solutions - MSN
Prudential Financial Inc. Takes Position in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Study Shows Cyberknife System Beneficial for Treating CNS Tumors - Imaging Technology News
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now - Yahoo Finance
Accuray CyberKnife® Platform Featured in New Studies Showcasing its Benefits in Central Nervous System Tumors Presented at Radiosurgery Society Scientific Meeting - MarketScreener
Breakthrough 25-Year Study Reveals CyberKnife's 89% Cancer Treatment Success - Stock Titan
Biotricity (NASDAQ:BTCY) & Accuray (NASDAQ:ARAY) Financial Review - The AM Reporter
Accuray Incorporated (NASDAQ:ARAY): When Will It Breakeven? - Yahoo Finance
Connor Clark & Lunn Investment Management Ltd. Raises Stock Position in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Accuray (NASDAQ:ARAY) Upgraded at StockNews.com - Defense World
Accuray (NASDAQ:ARAY) Is Experiencing Growth In Returns On Capital - Yahoo Finance
Accuray to Participate at 37th Annual Roth Conference - PR Newswire
Accuray Inc (ARAY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.93%
자본화:
|
볼륨(24시간):